burping with glp 1 “Sulfur burps” in patients on GLP-1 therapies may be more than a minor side effect. Experts note these symptoms can reflect underlying gastrointestinal changes linked to the drugs’ mechanism of GLP-1 SOS™ Digestive Support for

This is not a rare or unusual precaution in longevity medicine: the same consideration applies to GH secretagogues, IGF-1-stimulating peptides, and other compounds that promote cellular proliferative activity

The technical definition of treatment discontinuation had a substantial impact on the findings in our study

Disclaimer: This content is not intended as a substitute for professional medical advice, diagnosis, or treatment

When the drug is stopped, most patients regain weight

Ambulatory monitoring Holter monitors (2448 hours) or patch/event monitors (days to weeks) track heart rhythm over time and aim to capture an episode

3000mg per serving X 31 servings.* Was this helpful